Eli Lilly shares have room to keep going as GLP-1 drugs spread their reach.

Heard on the Street: Eli Lilly’s weight-loss drugs are lifting the company toward membership in the trillion-dollar club

Calley Means is set to take on a senior role at the Department of Health and Human Services.

Calley Means, a confidant to Health Secretary Robert F. Kennedy Jr., will take on a role as a bridge between the Make America Healthy Again movement and President Trump’s broader MAGA coalition

"Europe does not want to be the client" of the US or China in the field of technology, French President Emmanuel Macron told tech and political leaders gathered for a "digital sovereignty summit" in Berlin. At the event, biotech company Owkin unveiled a new pan-European platform to make biological data "AI-ready". CEO Thomas Clozel speaks to France 24 about how new agntic and reasoning models can help bring medical research to the next level.

As Europe aims for "digital sovereignty", biomedical agentic AI could be the next big field

Travelers and advocates say a rule at WestJet Airlines that prevents passengers from traveling with some wheelchairs is discriminating against people living with a disability.

WestJet weight cap on power wheelchairs leaves some Canadians grounded, advocates say

The Canadian Medical Association, which represents doctors nationwide, says Albertans will be left waiting longer to access health care if the province moves forward with the plan.

Alberta’s plan to let doctors work publicly and privately worries critics, health-care advocates

Opponents of the changes say Congress explicitly located some of these offices inside the Education Department, and the White House cannot legally move their work without Congress' approval.

Trump administration shares new moves to dismantle more of the Education Department

A survey by West Health-Gallup survey finds that nearly half of Americans are worried that they won't be able to afford health care next year. NBC News' Berkeley Lovelace Jr. reports on how rising prescription drug prices and expiring subsidies for the Affordable Care Act are affecting Americans' attitudes on healthcare.

تكشف دراسة استقصائية حديثة أجرتها ويست هيلث-غالوب أن ما يقرب من نصف الأمريكيين يشعرون بالقلق من عدم قدرتهم على تحمل تكاليف الرعاية الصحية في العام المقبل. إن ارتفاع أسعار الأدوية الموصوفة وانتهاء الدعم لبرنامج الرعاية الصحية الميسرة هما من العوامل الرئيسية التي تؤثر على هذه المخاوف. يذكر بيركلي لوفليس جونيور من NBC News أن هذه المخاوف المالية تشكل مواقف الجمهور تجاه الوصول إلى الرعاية الصحية و affordability مع اقتراب عام 2026.

Una reciente encuesta de West Health-Gallup revela que casi la mitad de los estadounidenses están preocupados por no poder costear la atención médica el próximo año. El aumento de los precios de los medicamentos recetados y la expiración de los subsidios de la Ley de Cuidado de Salud Asequible son factores significativos que influyen en estas preocupaciones. Berkeley Lovelace Jr. de NBC News informa que estas inquietudes financieras están moldeando las actitudes del público hacia el acceso y la asequibilidad de la atención médica a medida que se acerca 2026.

Une récente enquête West Health-Gallup révèle que près de la moitié des Américains s'inquiètent de ne pas pouvoir se permettre des soins de santé l'année prochaine. La hausse des prix des médicaments sur ordonnance et l'expiration des subventions de la Loi sur les soins abordables sont des facteurs significatifs influençant ces inquiétudes. Berkeley Lovelace Jr. de NBC News rapporte que ces préoccupations financières façonnent les attitudes du public envers l'accès et l'accessibilité des soins de santé à l'approche de 2026.

A recent West Health-Gallup survey reveals that nearly half of Americans are concerned about affording healthcare in the coming year. Rising prescription drug prices and the expiration of subsidies for the Affordable Care Act are significant factors influencing these worries. NBC News' Berkeley Lovelace Jr. reports that these financial concerns are shaping public attitudes towards healthcare access and affordability as the nation approaches 2026.

What Americans' top health care concerns are heading into 2026

The drugmaker said the results for giredestrant open the door to adding a treatment option at an early stage of the cancer, when most patients are diagnosed.

Heard on the Street: Eli Lilly’s weight-loss drugs are lifting the company toward membership in the trillion-dollar club

Was this article worth reading? Share it